Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Celldex Therapeutics, Inc. CLDX

Full chart Compare
Set alert

Price alert · CLDX

All alert types
29.63 USD +1.36 (+4.79%)

Nov 6, 2026, 12:57 PM EST

27.82 Day range 29.67
22.10 52-week range 45.14
YTD
+9.08%
1 year
+27.36%

Financial health

Altman Z-Score

14.11 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -7.0×
FY 2016: -2.8×FY 2017: -3.9×FY 2018: -0.2×FY 2019: -0.6×FY 2020: -8.7×FY 2021: -23.6×FY 2022: -18.6×FY 2023: -13.6×FY 2024: -10.3×FY 2025: -7.0×
FY 2016 5y median -13.6× FY 2025
P/S 1204×
FY 2016: 53.0×FY 2017: 28.6×FY 2018: 3.3×FY 2019: 9.1×FY 2020: 70.0×FY 2021: 356×FY 2022: 887×FY 2023: 279×FY 2024: 232×FY 2025: 1204×
FY 2016 5y median 356× FY 2025
P/B 3.4×
FY 2016: 1.4×FY 2017: 1.5×FY 2018: 0.3×FY 2019: 0.3×FY 2020: 2.5×FY 2021: 3.9×FY 2022: 6.4×FY 2023: 4.5×FY 2024: 2.2×FY 2025: 3.4×
FY 2016 5y median 3.9× FY 2025
P/FCF -8.5×
FY 2016: -3.1×FY 2017: -3.6×FY 2018: -0.4×FY 2019: -0.7×FY 2020: -12.4×FY 2021: -26.6×FY 2022: -19.8×FY 2023: -17.6×FY 2024: -10.2×FY 2025: -8.5×
FY 2016 5y median -17.6× FY 2025
EV/EBITDA -7.0×
FY 2016: -2.5×FY 2017: -3.2×FY 2018: -0.2×FY 2019: -0.5×FY 2020: -10.5×FY 2021: -24.5×FY 2022: -19.8×FY 2023: -13.6×FY 2024: -10.4×FY 2025: -7.0×
FY 2016 5y median -13.6× FY 2025
EV/Sales 1186×
FY 2016: 46.7×FY 2017: 26.0×FY 2018: 1.2×FY 2019: 6.9×FY 2020: 64.6×FY 2021: 348×FY 2022: 876×FY 2023: 274×FY 2024: 228×FY 2025: 1186×
FY 2016 5y median 348× FY 2025
FCF Yield -11.8%
FY 2016: -32.2%FY 2017: -27.9%FY 2018: -242.8%FY 2019: -145.7%FY 2020: -8.1%FY 2021: -3.8%FY 2022: -5.1%FY 2023: -5.7%FY 2024: -9.8%FY 2025: -11.8%
FY 2016 5y median -5.7% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: -1403.5%FY 2017: -654.7%FY 2018: -596.7%FY 2019: -1094.3%FY 2020: -473.4%FY 2021: -1046.2%FY 2022: -3389.9%FY 2023: -1614.5%FY 2024: -2229.8%FY 2025: 100.0%
FY 2016 5y median -1614.5% FY 2025
Operating Margin -19160.0%
FY 2016: -1958.7%FY 2017: -953.7%FY 2018: -1640.1%FY 2019: -1540.2%FY 2020: -854.1%FY 2021: -1531.8%FY 2022: -4889.0%FY 2023: -2245.3%FY 2024: -2778.9%FY 2025: -19160.0%
FY 2016 5y median -2778.9% FY 2025
Net Margin -17253.3%
FY 2016: -1894.0%FY 2017: -730.1%FY 2018: -1585.1%FY 2019: -1424.0%FY 2020: -805.9%FY 2021: -1516.0%FY 2022: -4765.6%FY 2023: -2054.8%FY 2024: -2248.8%FY 2025: -17253.3%
FY 2016 5y median -2248.8% FY 2025
ROE -49.1%
FY 2016: -48.4%FY 2017: -39.4%FY 2018: -121.9%FY 2019: -54.1%FY 2020: -28.6%FY 2021: -16.8%FY 2022: -34.4%FY 2023: -33.0%FY 2024: -21.1%FY 2025: -49.1%
FY 2016 5y median -33.0% FY 2025
ROIC -53.9%
FY 2016: -38.2%FY 2017: -32.7%FY 2018: -105.4%FY 2019: -48.6%FY 2020: -27.9%FY 2021: -16.5%FY 2022: -34.3%FY 2023: -35.4%FY 2024: -25.9%FY 2025: -53.9%
FY 2016 5y median -34.3% FY 2025
ROA -44.4%
FY 2016: -33.5%FY 2017: -29.5%FY 2018: -97.0%FY 2019: -41.4%FY 2020: -25.3%FY 2021: -15.9%FY 2022: -31.8%FY 2023: -30.4%FY 2024: -19.9%FY 2025: -44.4%
FY 2016 5y median -30.4% FY 2025

Growth (YoY)

Revenue -78.6%
FY 2016: 23.8%FY 2017: 87.8%FY 2018: -25.2%FY 2019: -62.5%FY 2020: 107.6%FY 2021: -37.3%FY 2022: -49.3%FY 2023: 192.0%FY 2024: 2.0%FY 2025: -78.6%
FY 2016 FY 2025
Operating Income -47.3%
FY 2016: -2.6%FY 2017: 8.6%FY 2018: -28.7%FY 2019: 64.8%FY 2020: -15.1%FY 2021: -12.5%FY 2022: -61.7%FY 2023: -34.1%FY 2024: -26.2%FY 2025: -47.3%
FY 2016 FY 2025
EPS (diluted) -59.2%
FY 2016: 3.4%FY 2017: 42.8%FY 2018: -33.3%FY 2019: 75.8%FY 2020: 42.5%FY 2021: 18.8%FY 2022: -46.3%FY 2023: -21.7%FY 2024: 16.1%FY 2025: -59.2%
FY 2016 FY 2025
Free Cash Flow -33.8%
FY 2016: -11.6%FY 2017: 12.1%FY 2018: 25.2%FY 2019: 38.0%FY 2020: 11.0%FY 2021: -48.2%FY 2022: -69.8%FY 2023: -3.4%FY 2024: -46.4%FY 2025: -33.8%
FY 2016 FY 2025

Financial Health

Current Ratio 10.5×
FY 2016: 5.6×FY 2017: 5.2×FY 2018: 7.9×FY 2019: 5.7×FY 2020: 13.9×FY 2021: 24.9×FY 2022: 17.1×FY 2023: 13.9×FY 2024: 18.9×FY 2025: 10.5×
FY 2016 5y median 17.1× FY 2025
Quick Ratio 10.5×
FY 2016: 5.6×FY 2017: 5.2×FY 2018: 7.9×FY 2019: 5.7×FY 2020: 13.9×FY 2021: 24.9×FY 2022: 17.1×FY 2023: 13.9×FY 2024: 18.9×FY 2025: 10.5×
FY 2016 5y median 17.1× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.9×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31